TK1 and metastatic prostate carcinoma: This finding was consistent with a previous study by Murtola et al. (2020), which established that serum TK1 levels were significantly higher in men with de novo metastatic prostate cancer compared to those without metastasis, indicating a potential association between higher TK1 levels and more advanced cancer stage.